Skip to main content
. 2003 Mar;18(3):196–202. doi: 10.1046/j.1525-1497.2003.20203.x

Retrospective Change Scenario for COPD Disease Patient No. 3

Basic Information:
Age: 66
Sex: female
Disease diagnosis:  COPD
Comorbid diagnoses: Current medications:
 Schizophrenia  albuterol inhaler
 hypertension  pseudoephedrine
 knee pain  Maxzide
 positive PPD  trifluoperazine
Visit No. 1:  4/11/95
Clinical information:
  History: Patient seen in Medicine Clinic one month previously for runny nose, productive cough with yellow sputum, and dyspnea on exertion. Oxygen saturation at that time was 93% (FIO2 not specified). On previous visit, she had end-expiratory wheezes without crackles. Patient was given the diagnosis at that visit of bronchitis with COPD exacerbation, and treated with amoxicillin, pseudoephedrine, and albuterol inhaler prn. Also scheduled pulmonary function studies. On 4/11/95, patient complained of swelling in her abdomen and feeling a “knot” in her right lower quadrant. She had a history of cervical and breast cancer.
  Physical exam: BP 172/89, pulse 89, weight 166 (increased 6 lbs over past month). Abdomen obese without masses or organomegaly. No other examination documented.
  Test results: FEV1 1.29 liters (63% of predicted), FVC 2.18 (78% of predicted).
  Treatment plan: Continue inhalers. Obtain CT scan for questionable abdominal mass. Follow-up in 1-2 months to Medicine Clinic.
Changes in treatment:: Restart Maxzide for hypertension.
Visit No. 2:  10/17/95
Clinical Information:
  History: Patient doing well. Out of blood pressure medications. Only 1 episode of wheezing in the last few months.
  Physical exam: BP 168/80, pulse 84, weight 181 (increased 15 lbs). Lungs clear. Neck without bruits. Heart with an S4 gallop, but no S3.
  Test results: CT scan showed renal cyst and ventral hernia.
  Treatment plan: Continue albuterol as needed for COPD/reactive airways disease. Continue isradipine for hypertension. Follow-up in 6-7 months to Medicine Clinic; get mammogram at that time.
Changes in treatment: Discontinue Maxzide for hypertension.
HEALTH-RELATED QUALITY OF LIFE DATA
Domains of the CHQ Interview 1 Date: 4/17/95 Interview 2 Date: 10/17/95 Change (T2 − T1)
Dyspnea 35 31 −4
Fatigue 18 25 7
Emotional Function 36 39 3
Mastery 20 27 7
Domains of the SF-36
Physical Functioning 60.00 33.33 −26.67
Role-Physical 100.00 100.00 0.00
Bodily Pain 100.00 100.00 0.00
General Health Perception 78.33 87.00 8.67
Vitality 70.00 65.00 −5.00
Social Functioning 100.00 100.00 0.00
Role-Emotional 100.00 100.00 0.00
Mental Health 60.00 76.00 16.00